Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma
about
Redox regulation of T-cell function: from molecular mechanisms to significance in human health and diseaseMonitoring the systemic human memory B cell compartment of melanoma patients for anti-tumor IgG antibodiesMonitoring of the Immune Dysfunction in Cancer PatientsDendritic cell-based vaccine efficacy: aiming for hot spotsEnhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine.Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients.Infiltrative T regulatory cells in enucleated uveal melanomas.The role of regulatory T cells in cancer.Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity.Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice.Immune response to JC virus T antigen in patients with and without colorectal neoplasia.NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartment.FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesionsA cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma.ZnT8-Specific CD4+ T cells display distinct cytokine expression profiles between type 1 diabetes patients and healthy adultsTumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice.Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns.Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockadeMerkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasiaPrognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patients.Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo.Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.Tumor Inhibition by DepoVax-Based Cancer Vaccine Is Accompanied by Reduced Regulatory/Suppressor Cell Proliferation and Tumor InfiltrationIn silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination.CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three casesTumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance.Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.Enhancing cancer immunotherapy by intracellular delivery of cell-penetrating peptides and stimulation of pattern-recognition receptor signaling.Regulatory T cells and treatment of cancer.How numbers, nature, and immune status of foxp3(+) regulatory T-cells shape the early immunological events in tumor developmentDevelopment of multi-epitope vaccines targeting wild-type sequence p53 peptides.Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function.Dendritic cells: a critical player in cancer therapy?Adoptive transfer of virus-specific and tumor-specific T cell immunityAntigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma.Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab.Influence of human immune cells on cancer: studies at the University of Colorado.Harnessing human dendritic cell subsets for medicine.
P2860
Q26824042-765D3B84-C7CE-44AB-82DB-170DBB7EC8CDQ27345217-D2C33E5C-C73F-410E-8CC7-CC459C304243Q28072712-2F009AFA-60FA-4093-B4C9-2F4BC97B8A71Q28082680-D5CAB2E7-FFEA-4D6F-9895-BE26561DABCCQ30355360-B22A84E3-9AFF-4951-9D77-170319288C6EQ33587584-CE84592F-05BA-4030-A613-E189E4DEFC4FQ33623491-ED65FB64-5FF6-4357-BDFB-B9D6CC295BB6Q33631986-329DEDAF-4E6F-4B62-943B-BBD579D4B78EQ33679779-917A283A-340F-4E4C-8FE1-0D06CA95A10CQ33730129-0AB7A71C-FD7F-4B3F-87C2-F56B3EADB3E6Q33894831-A1BDF5A5-2043-442D-AEEF-DF2A0857E664Q33915258-F7829B80-CCB6-4CFD-9B04-DE26F3F2C198Q33987977-4C7A93DE-7A60-4A99-9B8D-573704ADC5FDQ34197717-F9DCB7F0-C972-4722-9D43-23043F2890DCQ34461203-8F84505C-7992-4066-8A2B-0855D7018BE6Q34580119-CD52051A-DB79-434E-B618-53731993DA9EQ34610483-69554A6E-F70B-452A-8D87-3DC6AEB096F8Q34626852-E72BD2C7-59F3-4A00-8B32-A2FC1CA6F6DEQ34645401-6991727E-F625-4527-957A-196787DCA7C0Q35510910-F398F906-7392-4E0E-8C6B-7861992473CBQ36172036-ED1F9C2F-1C2D-45D1-B8AF-7A690943CC92Q36198776-5E0E5000-A764-4151-8C98-9697DCCC37CAQ36278320-6763F74B-5E24-4FD6-B24F-539629B24A58Q36526999-D0616022-8B45-4F91-9B74-9D4620DE7144Q36711835-93A31721-D817-48AA-9EC4-83C110033EF9Q36786874-3319E53E-6068-4876-A052-6A02F1D8B7D8Q36846646-38A9FDD0-AF92-40C9-96C0-DE9AC52B385FQ37028767-DB0E47B8-270D-4FDC-B5EA-F4778EA6E37CQ37040516-25335B1F-DFF3-42C3-8223-11CE4E05448DQ37139813-26A830A4-13CD-4625-AE9C-4CD71E5B438BQ37174953-9DF9267A-6EDE-4EFB-8B68-373E4F07B8EEQ37199750-675255E6-74AF-4AD6-903B-409A9ACF50B6Q37259621-589B5FB4-20F1-4BCD-81B9-530029316D05Q37266974-FE32058D-066E-4C8D-B438-648FAA52D451Q37276138-7F30AB90-A50B-4ABC-AD49-CA862D0E02DBQ37287275-AA6FDAB2-E8C2-4DAC-A911-F2BCAB1FD49EQ37403114-27301ED3-49C1-4A6C-98F7-0F1E91EE44B3Q37548776-7D51CBCE-6F06-4B52-BF14-D2167F05FA68Q37698684-FB0F255E-D4C0-4231-B924-659435F626F5Q37700841-E8CFBC73-A583-4E45-832D-50216A3ABA31
P2860
Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Circulating tumor antigen-spec ...... ients with metastatic melanoma
@ast
Circulating tumor antigen-spec ...... ients with metastatic melanoma
@en
type
label
Circulating tumor antigen-spec ...... ients with metastatic melanoma
@ast
Circulating tumor antigen-spec ...... ients with metastatic melanoma
@en
prefLabel
Circulating tumor antigen-spec ...... ients with metastatic melanoma
@ast
Circulating tumor antigen-spec ...... ients with metastatic melanoma
@en
P2093
P2860
P356
P1476
Circulating tumor antigen-spec ...... ients with metastatic melanoma
@en
P2093
A Karolina Palucka
Joseph W Fay
Luis Vence
Tomoki Ito
Yong-Jun Liu
P2860
P304
20884-20889
P356
10.1073/PNAS.0710557105
P407
P577
2007-12-18T00:00:00Z